Embryology News and Research

RSS

Embryology is the study of the development of an embryo. An embryo is defined as any organism in an early stage well before birth or hatching, or in plants, before germination occurs.

Cryo-Cell formalizes industry-exclusive agreement with MedTech For Solutions GPO

Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks and global stem cell innovators, today announced at the annual meeting of the American Society of Reproductive Medicine (ASRM) that the Company has formalized an industry-exclusive agreement with MedTech For Solutions, Inc., a Group Purchasing Organization (GPO) representing a member network of 115 practices specializing in reproductive medicine, which operates in conjunction with The Broadlane Group.

26 Oct 2010

CECOFLES to present results of fertility treatment cycles at ASRM Annual Meeting

INVO Bioscience, Inc. a medical device company focused on treatment options for patients diagnosed with infertility, today announced that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOFLES LTDA) will present the results of the first 95 fertility treatment cycles undertaken at the Center utilizing INVO Bioscience's INVOcell technology at the 66th Annual Meeting of the American Society for Reproductive Medicine on October 26, 2010 in Denver, Colorado.

25 Oct 2010

New set of guidelines for Preimplantation Genetic Diagnosis Screening

The European Society of Human Reproduction and Embryology (ESHRE) has published a set of guidelines for best practice Preimplantation Genetic Diagnosis (PGD)/Screening (PGS) to give information and guidance to potential and existing PGD centres.

22 Oct 2010

Australian stem cell line offers fresh approach to diabetes cure

Australian researchers have developed the country’s first diabetes specific stem cell line, a major advance for patients suffering from the chronic disease.

21 Oct 2010

ESHRE study shows advantages of CGH technique in IVF procedure

Two women taking part in the world's first controlled study of a comprehensive genetic screening test before IVF have given birth to healthy babies. The babies, twin girls born in Germany in June and a singleton boy born in Italy in September, are the first deliveries in a pilot study of comparative genomic hybridisation (CGH) by microarray, a new method of screening oocytes for IVF for a full range of chromosomal disorders.

18 Oct 2010

Births in Italy and Germany from eggs tested by CGH

15 Oct 2010

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

14 Oct 2010

Taller kids with IVF: Study

A new study has found that children born via IVF are typically taller than those born naturally. Newborn IVF babies created from a fresh embryo transferred back into the mother, also tended to be about 190g lighter than naturally conceived children.

13 Oct 2010

New York Stem Cell Foundation names first six NYSCF Investigators

In an expansion of its ongoing effort to promote the next generation of stem cell scientists, The New York Stem Cell Foundation (NYSCF) today named the first six NYSCF Investigators. Each of the NYSCF-Robertson and NYSCF-Helmsley Investigators will receive up to $1.5 million over the next five years to expand their own laboratories, train other scientists and foster innovative high-risk/high reward research to explore the therapeutic potential of stem cells derived from humans and model organisms.

13 Oct 2010

Baby born from 20 year old frozen embryo

A 42 year old mother gave birth to a baby born from an embryo frozen 20 years ago. This is the longest time a fertilized egg has been stored before developing into a healthy baby, and could eventually lead to thousands of women having children in middle age feel experts.

11 Oct 2010

European infertility patients are limited in choice for medically assisted reproduction treatment

In a number of European countries, infertility patients are limited in their choice for medically assisted reproduction treatment, experts criticized today at the European Health Forum Gastein. Many patients seek treatment outside their home countries.

6 Oct 2010

ESHRE workshop highlights problems related to MAR treatment in Europe

European patients are in many countries, in fact, limited in their individual choice of medically assisted reproduction (MAR) treatment, experts from the European Society of Human Reproduction and Embryology (ESHRE) stressed today at the European Health Forum Gastein (EHFG).

6 Oct 2010

Father of IVF acknowledged with a Nobel prize

Professor Robert Edwards who came to be known as the “father of In Vitro fertilization” (IVF) has won this year's Nobel prize in medicine. He is 85 and has won the 2010 Nobel Prize in Physiology and Medicine for his pioneering work on the in vitro fertilisation of human eggs that led to the birth of the world's first IVF baby, Louise Brown, in 1978. When he had started off initially his funding request for IVF research was turned down by Britain’s Medical Research Council (MRC) in the 1970s. His co-worker the gynaecologist Patrick Steptoe, died in 1988. Professor Edwards becomes the sole recipient of this award since it cannot be awarded posthumously.

4 Oct 2010

New sperm freezing technique may be a boon for IVF

A new improved method of freezing and storing sperm for future use in infertility treatment has arrived as a boon for couples wanting babies.

16 Sep 2010

Survey highlights safety concerns of patients crossing borders for infertility treatment

The European Society of Human Reproduction and Embryology (ESHRE) and the International Federation of Fertility Societies (IFFS) are concerned that the safety of patients crossing borders is no longer assured due to lack of uniform clinical and safety standards between the different countries. Additionally patients returning home often face legal and medical complications, as local health services take on the responsibility for treatment initiated abroad.

14 Sep 2010

University of Melbourne and Australian Regenerative Medicine Institute adopt BioEYES outreach program

Baltimore, MD-The innovative, educational, outreach program BioEYES has now been adopted by the University of Melbourne and the Australian Regenerative Medicine Institute. The down-under partnership program debuts this August. BioEYES is designed to foster an interest in and a love for science in elementary, middle, and high school students. Over the course of one week, students watch the transparent zebrafish, Danio rerio, grow from a single-celled zygote to a larval fish complete with a beating heart.

24 Aug 2010

Evaluation of medical reasons behind end to pregnancy due to abnormalities of fetus important

When a pregnancy ends tragically due to fatal abnormalities of the fetus, it is important to understand the medical reasons behind the event. This evaluation can help predict the risk of reoccurrence in future pregnancies. In the case of fetal akinesia deformation sequence (FADS), the fetus may have been affected by a disrupting injury or unavoidable maldevelopment.

18 Aug 2010

Highlights on reasoning behind MRC's negative decision on funding of IVF

Thirty-two years ago today, the world's first baby was born after in vitro fertilisation. However, the work that led to the birth of Louise Brown on 25 July 1978 had to be privately funded after the UK's Medical Research Council decided in 1971 against providing the Cambridge physiologist Robert Edwards and the Oldham gynaecologist Patrick Steptoe with long-term financial support. Today, an intriguing paper published in Europe's leading reproductive medicine journal Human Reproduction reveals for the first time the reasoning behind the MRC's much-criticised decision.

26 Jul 2010

EU requirement for HIV, hepatitis screening of ART couples at each donation unnecessary, distressing

European legislation that requires all couples undergoing assisted reproduction treatment (ART) to be screened for HIV and hepatitis at the time of every sperm or egg donation is unnecessary, expensive, and potentially distressing for patients, the 26th annual meeting of the European Society of Human Reproduction and Embryology heard Monday.

2 Jul 2010

Babies born after IVM fertility treatment more likely to be born larger than normal

A review of studies of babies born after in vitro maturation (IVM) fertility treatment has suggested that they are more likely to be born larger than normal and to have more difficult births requiring more obstetric interventions such as caesareans.

1 Jul 2010